SAN DIEGO, Aug. 31, 2017 -- Kratos Defense & Security Solutions, Inc. (Nasdaq:KTOS), a leading National Security Solutions provider, announced today that its Unmanned Systems Division (USD) has recently received $2.2 million in contract awards for one of its newest high performance jet powered unmanned aerial drone aircraft and related services. This new unmanned drone system is scheduled to be delivered within the next 12 months. Kratos USD is a leading provider of high performance jet powered unmanned aerial drone systems for tactical and target threat emulation requirements. Work under these contract awards will be performed at a secure Kratos manufacturing facility, and at customer locations. Due to competitive, customer related and other considerations, no additional information will be provided related to these contract awards.
Steve Fendley, President of Kratos Unmanned Systems Division, said, “Kratos is focused on rapidly designing, demonstrating, and fielding the highest performance unmanned aerial drone systems in the world, and we are very proud to be working with this important customer on this next generation UAS.”
About Kratos Defense & Security Solutions
Kratos Defense & Security Solutions, Inc. (NASDAQ:KTOS) develops transformative, affordable technology for the Department of Defense and commercial customers. Kratos is changing the way breakthrough technology for these industries are brought to market through proactive research and a streamlined development process. Kratos specializes in unmanned systems, satellite communications, cyber security/warfare, microwave electronics, missile defense, training and combat systems. For more information go to www.kratosdefense.com.
Notice Regarding Forward-Looking Statements
Certain statements in this press release may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are made on the basis of the current beliefs, expectations and assumptions of the management of Kratos and are subject to significant risks and uncertainty. Investors are cautioned not to place undue reliance on any such forward-looking statements. All such forward-looking statements speak only as of the date they are made, and Kratos undertakes no obligation to update or revise these statements, whether as a result of new information, future events or otherwise. Although Kratos believes that the expectations reflected in these forward-looking statements are reasonable, these statements involve many risks and uncertainties that may cause actual results to differ materially from what may be expressed or implied in these forward-looking statements. For a further discussion of risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of Kratos in general, see the risk disclosures in the Annual Report on Form 10-K of Kratos for the year ended December 25, 2016, and in subsequent reports on Forms 10-Q and 8-K and other filings made with the SEC by Kratos.
Press Contact: Yolanda White 858-812-7302 Direct Investor Information: 877-934-4687 [email protected]


Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
First Western Ship Transits Strait of Hormuz Since Iran War Began
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
Brazil Meat Exports Weather Iran War Disruptions With Rerouted Shipments
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
Apple Turns 50: From Garage Startup to AI Crossroads
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
Bank of America's $72.5M Epstein Settlement: What You Need to Know
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026 



